Mangiferin Enhances Endochondral Ossification‐based Bone Repair in Massive Bone Defect by Inducing Autophagy Through Activating AMP‐activated Protein Kinase Signaling Pathway
Yun Bai,Chuan Liu,Lei Fu,Xiaoshan Gong,Ce Dou,Zhen Cao,Hongyu Quan,Jianmei Li,Fei Kang,Jingjin Dai,Chunrong Zhao,Shiwu Dong
DOI: https://doi.org/10.1096/fj.201701411r
2018-01-01
The FASEB Journal
Abstract:Endochondral ossification is crucial for bone formation in both adult bone repair process and embryo long‐bone development. In endochondral ossification, bone marrow‐derived mesenchymal stem cells (BMSCs) first differentiate to chondrocytes, then BMSC‐derived chondrocytes endure a hypertrophic process to generate new bone. Endochondral ossification‐based bone repair is a promising strategy to cure massive bone defect, which is a major clinical issue in orthopedics. However, challenges still remain for this novel strategy. One challenge is to ensure the sufficient hypertrophic differentiation. Another is to maintain the survival of the above hypertrophic chondrocytes under the hypoxic environment of massive bone defect. To solve this issue, mangiferin (MAG) was introduced to endochondral ossification‐based bone repair. In this report, we proved MAG to be a novel autophagy inducer, which promoted BMSC‐derived hypertrophic chondrocyte survival against hypoxia‐induced injury through inducing autophagy. Furthermore, MAG enhances hypertrophic differentiation of BMSC‐derived chondrocytes via upregu‐lating key hypertrophic markers. Mechanistically, MAG induced autophagy in BMSC‐derived chondrocytes by promoting AMPKa phosphorylation. Additionally, MAG balanced the expression of sex‐determining region Y‐box 9 and runt‐related transcription factor 2 to facilitate hypertrophic differentiation. These results indicated that MAG was a potential drug to improve the efficacy of endochondral ossification‐based bone repair in massive bone defects.—Bai, Y., Liu, C., Fu, L., Gong, X., Dou, C., Cao, Z., Quan, H., Li, J., Kang, F., Dai, J., Zhao, C., Dong, S. Mangiferin enhances endochondral ossification‐based bone repair in massive bone defect by inducing autophagy through activating AMP‐activated protein kinase signaling pathway. FASEB J. 32, 4573–4584 (2018). www.fasebj.org